S. B. Telek Et Al. , "Oral Gonadotropin-Releasing Hormone Antagonists in the Treatment of Uterine Myomas: A Systematic Review and Network Meta-analysis of Efficacy Parameters and Adverse Effects," Journal of Minimally Invasive Gynecology , vol.29, no.5, pp.613-625, 2022
Telek, S. B. Et Al. 2022. Oral Gonadotropin-Releasing Hormone Antagonists in the Treatment of Uterine Myomas: A Systematic Review and Network Meta-analysis of Efficacy Parameters and Adverse Effects. Journal of Minimally Invasive Gynecology , vol.29, no.5 , 613-625.
Telek, S. B., Gurbuz, Z., KALAFAT, E., & Ata, B., (2022). Oral Gonadotropin-Releasing Hormone Antagonists in the Treatment of Uterine Myomas: A Systematic Review and Network Meta-analysis of Efficacy Parameters and Adverse Effects. Journal of Minimally Invasive Gynecology , vol.29, no.5, 613-625.
Telek, Savci Et Al. "Oral Gonadotropin-Releasing Hormone Antagonists in the Treatment of Uterine Myomas: A Systematic Review and Network Meta-analysis of Efficacy Parameters and Adverse Effects," Journal of Minimally Invasive Gynecology , vol.29, no.5, 613-625, 2022
Telek, Savci B. Et Al. "Oral Gonadotropin-Releasing Hormone Antagonists in the Treatment of Uterine Myomas: A Systematic Review and Network Meta-analysis of Efficacy Parameters and Adverse Effects." Journal of Minimally Invasive Gynecology , vol.29, no.5, pp.613-625, 2022
Telek, S. B. Et Al. (2022) . "Oral Gonadotropin-Releasing Hormone Antagonists in the Treatment of Uterine Myomas: A Systematic Review and Network Meta-analysis of Efficacy Parameters and Adverse Effects." Journal of Minimally Invasive Gynecology , vol.29, no.5, pp.613-625.
@article{article, author={Savci Bekir Telek Et Al. }, title={Oral Gonadotropin-Releasing Hormone Antagonists in the Treatment of Uterine Myomas: A Systematic Review and Network Meta-analysis of Efficacy Parameters and Adverse Effects}, journal={Journal of Minimally Invasive Gynecology}, year=2022, pages={613-625} }